Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tosoh Corp.

Latest From Tosoh Corp.

Avitide Rolls Out Series A to Launch Biologics Purification Co.

Avitide Inc. raised an undisclosed Series A financing from a strong and familiar syndicate to provide custom affinity purification solutions to biologics manufacturers.

Prostate Cancer Market: $2 Billion and Growing

Although prostate problems have plagued men for many years, the growing elderly population is now driving an unprecedented increase in caseloads and a corresponding need for improved treatments. One of the primary concerns is the rise in prostate cancer diagnoses. With more than two million American men currently living with prostate cancer and more than 200,000 new cases diagnosed each year, the market for diagnostic and therapeutic products to address this disease is substantial; more than $2 billion in the US in 2007.
Medical Device

Cardiac Diagnostics and the Challenge of ER Testing

More than 10 years after it was introduced on a broad scale in non-glucose applications, point-of-care testing (POCT) has found a place in carefully selected niches in hospitals. It's still not part of mainstream care, however. Data indicating the importance of getting rapid test results on cardiac markers, notably troponins and BNP, is tempting POCT in vitro diagnostics manufacturers to forge closer relationships with non-lab clinicians, even as they cater to their core, but resistant, laboratory customer base. Manufacturers are going to have to make their devices smaller, easier to use, cheaper, and better connected to data management systems if they want to lower the central labs' resistance to POCT.
Medical Device Platform Technologies

Unmiring International Murex

Murex's loss to Chiron over the hepatitis C patent didn't kill it, but the company must establish its monitoring business--quickly.
Medical Device North America
See All

Company Information

  • Industry
  • Diversified
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Tosoh Corp.
  • Senior Management
  • Minoru Aoyama, Group General Mgr.
  • Contact Info
  • Tosoh Corp.
    Phone: (81) 35 869 141
    1-11-39, Akasaka, Minato-ku
    Tokyo 107,